Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.

Abstract:

:Recently various genetic defects in immunity mediated by interferon gamma (IFN-gamma) have been described, including mutations in the IFN-gamma receptor 1 (IFN-gammaR1) and receptor 2 (IFN-gammaR2), signal transducer and activator of transcription 1 (STAT 1), and interleukin 12 receptor beta 1 (IL-12Rbeta1), and IL-12 p40 genes. These mutations are associated with the occurrence of severe infections with intracellular pathogens especially nontuberculous mycobacteria and vaccine-associated bacilli Calmette-Guérin (BCG). Here we report data on a previously healthy adult patient primarily presenting with severe infections with Burkholderia cocovenenans and subsequently Mycobacterium cheloneae. We found a strong inhibitory anti-IFN-gamma activity in the patient's plasma and identified a high-affinity neutralizing anti-IFN-gamma autoantibody. Unfortunately, the patient died due to severe sepsis before we knew the nature of the inhibitory activity. The application of alternative therapeutic approaches such as intravenous immunoglobulin or immunoadsorption may have been beneficial in this case. Screening for neutralizing anti-IFN-gamma autoantibodies should supplement testing for IFN-gamma and IL-12 pathway defects in patients with recurrent infections with intracellular pathogens, especially with nontuberculous mycobacteria.

journal_name

Blood

journal_title

Blood

authors

Höflich C,Sabat R,Rosseau S,Temmesfeld B,Slevogt H,Döcke WD,Grütz G,Meisel C,Halle E,Göbel UB,Volk HD,Suttorp N

doi

10.1182/blood-2003-04-1065

subject

Has Abstract

pub_date

2004-01-15 00:00:00

pages

673-5

issue

2

eissn

0006-4971

issn

1528-0020

pii

2003-04-1065

journal_volume

103

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate.

    abstract::Cryoprecipitate has been demonstrated to correct the bleeding abnormality of patients with some congenital (storage pool disease) and acquired (uremia) platelet abnormalities, but the reason for this effect is unknown. We found significant platelet contamination in plasma harvested to prepare fresh frozen plasma and c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: George JN,Pickett EB,Heinz R

    更新日期:1986-07-01 00:00:00

  • A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling.

    abstract::Platelets contain and release several matrix metalloproteinases (MMPs). Among these, active MMP-2 enhances platelet aggregation by favoring the activation of phosphatidylinositol 3- kinase (PI3K) and contributes to arterial thrombosis. The platelet surface target of MMP-2 and the mechanism through which it primes plat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-724245

    authors: Sebastiano M,Momi S,Falcinelli E,Bury L,Hoylaerts MF,Gresele P

    更新日期:2017-02-16 00:00:00

  • A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia.

    abstract::Ibrutinib is highly efficacious and used at 420 mg/d for treatment of chronic lymphocytic leukemia (CLL). We previously demonstrated a decline in Bruton's tyrosine kinase (BTK) protein levels in CLL cells after 1 cycle of ibrutinib, suggesting ibrutinib dose could be lowered after the first cycle without loss of biolo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2018-06-860593

    authors: Chen LS,Bose P,Cruz ND,Jiang Y,Wu Q,Thompson PA,Feng S,Kroll MH,Qiao W,Huang X,Jain N,Wierda WG,Keating MJ,Gandhi V

    更新日期:2018-11-22 00:00:00

  • Erythropoietin stimulates a rise in intracellular-free calcium concentration in single BFU-E derived erythroblasts at specific stages of differentiation.

    abstract::Human cord blood progenitor-derived erythroblasts have recently been shown to respond to erythropoietin (Epo) or granulocyte-macrophage colony-stimulating factor (GM-CSF) with a transient increase in intracellular free calcium concentration [Cac]. However, the importance of [Cac] changes in mediating cell proliferatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miller BA,Cheung JY,Tillotson DL,Hope SM,Scaduto RC Jr

    更新日期:1989-04-01 00:00:00

  • Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro.

    abstract::Little is known about the molecular mechanisms controlling primitive hematopoietic stem cells, especially during embryogenesis. Homeobox genes encode a family of transcription factors that have gained increasing attention as master regulators of developmental processes and recently have been implicated in the differen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Helgason CD,Sauvageau G,Lawrence HJ,Largman C,Humphries RK

    更新日期:1996-04-01 00:00:00

  • Myc is essential for transformation by TEL/platelet-derived growth factor receptor beta (PDGFRbeta).

    abstract::The t(5;12) translocation identified in patients with chronic myelomonocytic leukemia (CMML) encodes a TEL/platelet-derived growth factor receptor beta (PDGFRbeta) fusion protein. A key hypothesis for how the TEL/PDGFRbeta fusion protein would function as an oncogene is that it represents a constitutively active versi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bourgeade MF,Défachelles AS,Cayre YE

    更新日期:1998-05-01 00:00:00

  • Human fetuses are able to mount an adultlike CD8 T-cell response.

    abstract::Fetal/neonatal immune responses generally are considered to be immature and weaker than that of adults. We have studied the cord-blood T cells of newborns congenitally infected with Trypanosoma cruzi, the protozoan agent of Chagas disease. Our data demonstrate a predominant activation of CD8 T cells expressing activat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hermann E,Truyens C,Alonso-Vega C,Even J,Rodriguez P,Berthe A,Gonzalez-Merino E,Torrico F,Carlier Y

    更新日期:2002-09-15 00:00:00

  • Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.

    abstract::Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called "synthetic lethality" was applied, which relies on the addic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-501072

    authors: Cramer-Morales K,Nieborowska-Skorska M,Scheibner K,Padget M,Irvine DA,Sliwinski T,Haas K,Lee J,Geng H,Roy D,Slupianek A,Rassool FV,Wasik MA,Childers W,Copland M,Müschen M,Civin CI,Skorski T

    更新日期:2013-08-15 00:00:00

  • Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia.

    abstract::Chronic lymphocytic leukemia of B-cell origin (B-CLL) is generally thought to arise by neoplastic transformation of B lymphocytes, which express CD5 and have features of an early stage of B-cell differentiation. To study isotype-switched B-CLL as a potentially more differentiated variant, we performed genetic and func...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Friedman DF,Moore JS,Erikson J,Manz J,Goldman J,Nowell PC,Silberstein LE

    更新日期:1992-11-01 00:00:00

  • Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells.

    abstract::This study was undertaken to gain further insight into the severely impaired natural killer (NK) activity we and others have previously observed in patients with chronic lymphocytic leukemia (CLL). Normal individuals' NK cells are large granular lymphocytes (LGL) that (A) bind to and lyse NK-sensitive cells, including...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kay NE,Zarling JM

    更新日期:1984-02-01 00:00:00

  • Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivors.

    abstract::Eleven of twenty-four patients with severe aplastic anemia given marrow grafts from HLA-identical siblings between October 1970 and March 1973 are alive with normal marrow function and continued evidence of engraftment 3-5 yr later. Ten have been leading normal lives with no immunosuppressive or other drug therapy sin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Storb R,Thomas ED,Buckner CD,Clift RA,Fefer A,Fernando LP,Giblett ER,Johnson FL,Neiman PE

    更新日期:1976-10-01 00:00:00

  • Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin.

    abstract::Recurrence of the underlying malignancy remains a major cause of treatment failure after autologous bone marrow transplantation (BMT) for patients with lymphoma. In this regard, we have developed an immunotherapeutic approach designed to induce resistance against residual tumor cells persisting after BMT. Previous stu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kwak LW,Campbell MJ,Zelenetz AD,Levy R

    更新日期:1990-12-01 00:00:00

  • Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas.

    abstract::Escape from immune detection favors both tumor survival and progression, and new approaches to circumvent this are essential to combat cancers. Nonvirulent, tumor-tropic bacteria, such as Salmonella typhimurium, can unmask a tumor by transforming it into a site of inflammation; however, the nonspecific invasiveness of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-474098

    authors: Massa PE,Paniccia A,Monegal A,de Marco A,Rescigno M

    更新日期:2013-08-01 00:00:00

  • Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

    abstract::Chemotherapy-related myeloid neoplasia (t-MN) is a significant late toxicity concern after cancer therapy. In the randomized intergroup phase 3 E2997 trial, initial therapy of chronic lymphocytic leukemia with fludarabine plus cyclophosphamide (FC) compared with fludarabine alone yielded higher complete and overall re...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-03-342485

    authors: Smith MR,Neuberg D,Flinn IW,Grever MR,Lazarus HM,Rowe JM,Dewald G,Bennett JM,Paietta EM,Byrd JC,Hussein MA,Appelbaum FR,Larson RA,Litzow MR,Tallman MS

    更新日期:2011-09-29 00:00:00

  • Structural integrity of the glycoprotein IIb and IIIa genes in Glanzmann thrombasthenia patients from Israel.

    abstract::Glanzmann thrombasthenia is an autosomal recessive disorder of the platelet glycoproteins (GP) IIb and IIIa. These glycoproteins normally serve as receptors for other adhesive glycoproteins, including fibrinogen, von Willebrand factor, and fibronectin. Most patients affected by Glanzmann thrombasthenia have low levels...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Russell ME,Seligsohn U,Coller BS,Ginsberg MH,Skoglund P,Quertermous T

    更新日期:1988-11-01 00:00:00

  • RUNX1 regulates corepressor interactions of PU.1.

    abstract::The transcription factor (TF) RUNX1 cooperates with lineage-specifying TFs (eg, PU.1/SPI1) to activate myeloid differentiation genes, such as macrophage and granulocyte macrophage colony-stimulating factor receptors (MCSFR and GMCSFR). Disruption of cooperative gene activation could contribute to aberrant repression o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-10-312512

    authors: Hu Z,Gu X,Baraoidan K,Ibanez V,Sharma A,Kadkol S,Munker R,Ackerman S,Nucifora G,Saunthararajah Y

    更新日期:2011-06-16 00:00:00

  • Human serum megakaryocyte colony-stimulating activity appears to be distinct from interleukin-3, granulocyte-macrophage colony-stimulating factor, and lymphocyte-conditioned medium.

    abstract::Sera from patients with bone marrow megakaryocyte aplasia are a rich source of megakaryocyte colony-stimulating activity (Meg-CSA). Other biologic materials exhibiting Meg-CSA include phytohemagglutinin-stimulated human lymphocyte-conditioned medium (PHA-LCM), recombinant interleukin-3 (IL-3), and recombinant granuloc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mazur EM,Cohen JL,Newton J,Sohl P,Narendran A,Gesner TG,Mufson RA

    更新日期:1990-07-15 00:00:00

  • Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B.

    abstract::Human early thymic precursors have the potential to differentiate into multiple cell lineages, including T cells and plasmacytoid dendritic cells (pDCs). This decision is guided by the induction or silencing of lineage-specific transcription factors. The ETS family member Spi-B is a key regulator of pDC development, w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-2090

    authors: Dontje W,Schotte R,Cupedo T,Nagasawa M,Scheeren F,Gimeno R,Spits H,Blom B

    更新日期:2006-03-15 00:00:00

  • AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines.

    abstract::The PI3K/AKT signaling is activated in various hematologic malignancies. We evaluated the effect of a novel, pan-AKT kinase inhibitor, GSK690693, on the proliferation of 112 cell lines representing different hematologic neoplasia. Fifty-five percent of all cell lines tested were sensitive to AKT inhibitor (EC(50)<1 mi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-02-137737

    authors: Levy DS,Kahana JA,Kumar R

    更新日期:2009-02-19 00:00:00

  • MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.

    abstract::Anaplastic large-cell lymphomas (ALCLs) encompass at least 2 systemic diseases distinguished by the presence or absence of anaplastic lymphoma kinase (ALK) expression. We performed genome-wide microRNA (miRNA) profiling on 33 ALK-positive (ALK[+]) ALCLs, 25 ALK-negative (ALK[-]) ALCLs, 9 angioimmunoblastic T-cell lymp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-08-447375

    authors: Liu C,Iqbal J,Teruya-Feldstein J,Shen Y,Dabrowska MJ,Dybkaer K,Lim MS,Piva R,Barreca A,Pellegrino E,Spaccarotella E,Lachel CM,Kucuk C,Jiang CS,Hu X,Bhagavathi S,Greiner TC,Weisenburger DD,Aoun P,Perkins SL,McKeith

    更新日期:2013-09-19 00:00:00

  • Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray.

    abstract::An imbalance between cellular apoptosis and survival may be critical for the pathogenesis of lymphoma. Therefore, the gene expression pattern in lymph node preparations from patients with mantle cell lymphoma (MCL) was compared to the pattern in nonmalignant hyperplastic lymph nodes (HLs). Oligonucleotide microarray a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.787

    authors: Hofmann WK,de Vos S,Tsukasaki K,Wachsman W,Pinkus GS,Said JW,Koeffler HP

    更新日期:2001-08-01 00:00:00

  • Trial of repeated low-dose aspirin in diabetic angiopathy.

    abstract::We compared the ability of aspirin to suppress platelet aggregation and thromboxane synthesis in ten normal subjects and ten patients with diabetic angiopathy and high rate of entry of new platelets into the circulation. When single doses of 100 to 1,000 mg aspirin were ingested daily for 1 month, there were time gaps...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: DiMinno G,Silver MJ,Cerbone AM,Murphy S

    更新日期:1986-10-01 00:00:00

  • Prion protein expression in human leukocyte differentiation.

    abstract::The cellular isoform of the prion protein (PrPC) is a small glycoprotein attached to the outer leaflet of the plasma membrane by a glycosylphosphatidylinositol anchor. This molecule is involved in the pathogenesis of prion diseases in both humans and animals. We have characterized the expression patterns of PrPC durin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dodelet VC,Cashman NR

    更新日期:1998-03-01 00:00:00

  • Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1,25-dihydroxyvitamin D3 on human promonocytic leukemic cells.

    abstract::All trans retinoic acid and vitamin D3 derivatives are well known for their antileukemic activity, while the precise mechanism of this effect remains to be clarified. Using human leukemic U937 and THP-1 promonocytic cell lines, we analyzed the effect of all-trans retinoic acid (RA) and/or 1,25-dihydroxyvitamin D3 (VD)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dugas N,Mossalayi MD,Calenda A,Léotard A,Bécherel P,Mentz F,Ouaaz F,Arock M,Debré P,Dornand J,Dugas B

    更新日期:1996-11-01 00:00:00

  • Prevention and induction of occlusive coronary vascular disease in autoimmune (W/B)F1 mice by haploidentical bone marrow transplantation: possible role for anticardiolipin autoantibodies.

    abstract::Male (NZW x BXSB)F1 (W/BF1) mice develop systemic autoimmunity involving autoantibodies, thrombocytopenia, lupus nephritis, and coronary vascular disease with myocardial infarction (CVD). To determine whether this murine lupus-associated CVD could be transferred to otherwise autoimmune-resistant (C57BL/6 x C3H/He)F1 (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mizutani H,Engelman RW,Kinjoh K,Kurata Y,Ikehara S,Good RA

    更新日期:1993-11-15 00:00:00

  • Erythropoietin alone induces erythroid burst formation by human embryonic but not adult BFU-E in unicellular serum-free culture.

    abstract::Erythroid progenitors (BFU-E) from adult human peripheral blood generate erythroid bursts in semisolid culture supplemented with at least two growth factors, ie, erythropoietin (Ep) and interleukin-3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF). We have analyzed the hematopoietin(s) requirement ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Valtieri M,Gabbianelli M,Pelosi E,Bassano E,Petti S,Russo G,Testa U,Peschle C

    更新日期:1989-07-01 00:00:00

  • Role of GM-CSF signaling in cell-based tumor immunization.

    abstract::Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent adjuvant in cancer vaccination; however, the specific role of endogenous GM-CSF remains unknown. We performed cell-based vaccination in 2 tumor models. First, we vaccinated C57BL/6 mice lacking either GM-CSF, IL-5, or beta-common chain (betac), a re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-161075

    authors: Zarei S,Schwenter F,Luy P,Aurrand-Lions M,Morel P,Kopf M,Dranoff G,Mach N

    更新日期:2009-06-25 00:00:00

  • Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.

    abstract::The mechanism(s) underlying the release of stem/progenitor cells from bone marrow into the circulation is poorly understood. We hypothesized that matrix metalloproteinases (MMPs), especially gelatinases, which are believed to participate in the proteolysis of basement membranes and in the migration of leukocytes, may ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Janowska-Wieczorek A,Marquez LA,Nabholtz JM,Cabuhat ML,Montaño J,Chang H,Rozmus J,Russell JA,Edwards DR,Turner AR

    更新日期:1999-05-15 00:00:00

  • How I treat gastrointestinal bleeding in congenital and acquired von Willebrand disease.

    abstract::Gastrointestinal (GI) bleeding is distinctive of severe von Willebrand disease (VWD), generally arising in older patients; in most cases, blood transfusion and hospitalization are required. The presence of arteriovenous malformations is often described when endoscopic examinations are performed. Patients with congenit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003702

    authors: Biguzzi E,Siboni SM,Peyvandi F

    更新日期:2020-09-03 00:00:00

  • Enhancement of the biologic effects of interleukin-3 in vivo by anti-interleukin-3 antibodies.

    abstract::Interleukin-3 (IL-3) has been shown to be a promising agent in the stimulation of bone marrow regeneration following myeloablative therapy. The biologic half-life of this agent is very short (5 to 15 minutes), which limits the effectiveness of low-dose therapy. Here we show that the biologic effects of low-dose IL-3 i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jones AT,Ziltener HJ

    更新日期:1993-08-15 00:00:00